The MTNR1B rs10830963 Variant in Interaction with Pre-Pregnancy BMI is a Pharmacogenetic Marker for the Initiation of Antenatal Insulin Therapy in Gestational Diabetes Mellitus

Firneisz, Gábor; Rosta, Klara; Al-Aissa, Zahra; Hadarits, Orsolya; Harreiter, Jürgen; Nádasdi, Ákos; Bancher-Todesca, Dagmar; Németh, László; Igaz, Péter; Rigó, János

Date: 2018

URI: http://hdl.handle.net/10831/67099

MTMT: 30325428

WoS ID: 000455323500036

Scopus ID: 85057209385

PubMed ID: 30477160

DOI: 10.3390/ijms19123734

Show full item record

Files in this item

The MTNR1B rs10830963 Variant in Interaction with Pre-Pregnancy BMI is a Pharmacogenetic Marker for the Initiation of Antenatal Insulin Therapy in Gestational Diabetes Mellitus

Name: 30325428.pdf

Size: 248.6Kb

Format: PDF

Nevezd meg! CC BY

Except where otherwise noted, this item's license is described as Nevezd meg! CC BY